Pravastatin reduced nonfatal MI without increasing noncardiovascular death in men with hypercholesterolemia
Main Author: | Clarke, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1996
|
Similar Items
-
Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia.
by: PG Elmberger, et al.
Published: (1991-06-01) -
Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long‐Term Follow‐Up After Acute Coronary Syndromes
by: Alexander C. Fanaroff, et al.
Published: (2017-09-01) -
Genetic risk score for coronary disease identifies predispositions to cardiovascular and noncardiovascular diseases
by: Ntalla, I, et al.
Published: (2019) -
Association Between Life's Simple 7 and Noncardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
by: Oluseye Ogunmoroti, et al.
Published: (2016-10-01) -
Frailty as a Risk Factor for Cardiovascular Versus Noncardiovascular Mortality in Older Men: Results From the MrOS Sleep (Outcomes of Sleep Disorders in Older Men) Study
by: Selcuk Adabag, et al.
Published: (2018-05-01)